Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Pharmos Corporation (NasdaqSC:PARS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug  7Earnings Announcement
Location
99 Wood Avenue South, Suite 301
Iselin, NJ 08830
Phone: (732) 452-9556
Fax: (732) 452-9557
Email: pharmos@compuserve.com
Employees (last reported count): 66
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 3%
·Institutional: 5% (6% of float)
(39 institutions)
·Net Inst. Buying: 1.41M shares (+31.88%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Pharmos Corporation is a bio-pharmaceutical company that discovers and develops novel therapeutics to treat a range of inflammatory and neurological disorders, such as traumatic brain injury and stroke. The Company has an extensive portfolio of drug candidates under development, as well as discovery, preclinical and clinical capabilities. Dexanabinol, the Company's lead central nervous system product aimed initially at treating severe head trauma and stroke, is currently undergoing a pivotal Phase III clinical trial for severe traumatic brain injury in Europe.
More from Market Guide: Expanded Business Description

Financial Summary
Pharmos Corp. is a pharmaceutical co. engaged in the research and development of novel drugs based on innovative drug delivery technologies. PARS portfolio of drugs targets diseases of the eye and the Central Nervous System. For the six months ended 6/30/01, revenues rose 24% to $2.6 million. Net loss applicable to Common rose 86% to $5.1 million. Revenues reflect market share gains. Higher loss reflects increased staffing levels and activity in the cannabinoid program.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Haim Aviv, Ph.D., 61
Chairman, CEO and Chief Scientist
$322K$781K
Gad Riesenfeld, Ph.D., 57
Pres, COO, Sec.
285K481K
Robert Cook, 45
CFO, Exec. VP
229K215K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:PARSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$1.469
Recent Price$2.70 
52-Week High
on 5-Sep-2000
$4.563
Beta0.45 
Daily Volume (3-month avg)200.6K
Daily Volume (10-day avg)78.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-37.8%
52-Week Change
relative to S&P500
-16.6%
Share-Related Items
Market Capitalization$148.7M
Shares Outstanding55.1M
Float53.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 4 on 20-Oct-1993
Per-Share Data
Book Value (mrq)$0.27 
Earnings (ttm)-$0.19 
Earnings (mrq)-$0.04 
Sales (ttm)$0.10 
Cash (mrq)$0.32 
Valuation Ratios
Price/Book (mrq)9.96 
Price/EarningsN/A 
Price/Sales (ttm)25.95 
Income Statements
Sales (ttm)$5.61M
EBITDA (ttm)-$7.79M
Income available to common (ttm)-$10.4M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-36.55%
Return on Equity (ttm)-55.54%
Financial Strength
Current Ratio (mrq)2.34 
Debt/Equity (mrq)0.49 
Total Cash (mrq)$17.3M
Short Interest
As of 8-Aug-2001
Shares Short596.0K
Percent of Float1.1%
Shares Short
(Prior Month)
752.0K
Short Ratio5.05 
Daily Volume118.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.